The development of Burkitt cell leukemia (FABL3) [l] in a patient 7 years after successful treatment of Hodgkin's disease (HD) by combined modality (chemotherapy and radiotherapy) therapy is described. The B-cell nature of the leukemic blasts is shown by immunologic surface marker studies. While L3
Treatment related myelitis in hodgkin’s lymphoma following stem cell transplant, chemotherapy and radiation: a case report and review of the literature
✍ Scribed by Heather Gatcombe; Josh Lawson; Surasak Phuphanich; Ian Crocker
- Publisher
- Springer US
- Year
- 2006
- Tongue
- English
- Weight
- 342 KB
- Volume
- 79
- Category
- Article
- ISSN
- 0167-594X
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Non-Hodgkin's lymphomas presenting exclusively in the liver are rather uncommon in adults and extremely rare in children. We describe a six-year-old white boy with jaundice, abdominal pain, and weight loss of two weeks duration. Physical examination disclosed asthenia, jaundice, abdominal swelling,
## BACKGROUND. Renal transplant recipients have a high incidence of cancer. The main side effect of cisplatin, nephrotoxicity, has special implications in renal transplant recipients. This is particularly true in view of the routine use of cyclosporine as an inimunosuppresant. Nephrotoxicity is als